132 related articles for article (PubMed ID: 15296636)
1. Development of a fluorescence polarization assay for the molecular chaperone Hsp90.
Kim J; Felts S; Llauger L; He H; Huezo H; Rosen N; Chiosis G
J Biomol Screen; 2004 Aug; 9(5):375-81. PubMed ID: 15296636
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening fluorescence polarization assay for tumor-specific Hsp90.
Du Y; Moulick K; Rodina A; Aguirre J; Felts S; Dingledine R; Fu H; Chiosis G
J Biomol Screen; 2007 Oct; 12(7):915-24. PubMed ID: 17942784
[TBL] [Abstract][Full Text] [Related]
3. Improvement of inhibitor identification for heat shock protein 90α by utilizing a red-shifted fluorescence polarization probe.
Qian J; Holskin BP; Theroff J; Underiner T; Meyer SL; Angeles TS
Assay Drug Dev Technol; 2012 Aug; 10(4):375-81. PubMed ID: 22428803
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.
Onuoha SC; Mukund SR; Coulstock ET; SengerovĂ B; Shaw J; McLaughlin SH; Jackson SE
J Mol Biol; 2007 Sep; 372(2):287-97. PubMed ID: 17662999
[TBL] [Abstract][Full Text] [Related]
5. A time-resolved fluorescence resonance energy transfer-based HTS assay and a surface plasmon resonance-based binding assay for heat shock protein 90 inhibitors.
Zhou V; Han S; Brinker A; Klock H; Caldwell J; Gu XJ
Anal Biochem; 2004 Aug; 331(2):349-57. PubMed ID: 15265741
[TBL] [Abstract][Full Text] [Related]
6. Binding of immunophilins to the 90 kDa heat shock protein (hsp90) via a tetratricopeptide repeat domain is a conserved protein interaction in plants.
Owens-Grillo JK; Stancato LF; Hoffmann K; Pratt WB; Krishna P
Biochemistry; 1996 Dec; 35(48):15249-55. PubMed ID: 8952474
[TBL] [Abstract][Full Text] [Related]
7. A novel chaperone-activity-reducing mechanism of the 90-kDa molecular chaperone HSP90.
Itoh H; Ogura M; Komatsuda A; Wakui H; Miura AB; Tashima Y
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):697-703. PubMed ID: 10527951
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Hsf1 activity by novobiocin and geldanamycin.
Conde R; Belak ZR; Nair M; O'Carroll RF; Ovsenek N
Biochem Cell Biol; 2009 Dec; 87(6):845-51. PubMed ID: 19935870
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of a red-shifted fluorescence polarization probe for Hsp90.
Moulick K; Clement CC; Aguirre J; Kim J; Kang Y; Felts S; Chiosis G
Bioorg Med Chem Lett; 2006 Sep; 16(17):4515-8. PubMed ID: 16797988
[TBL] [Abstract][Full Text] [Related]
10. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate.
Thulasiraman V; Matts RL
Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613
[TBL] [Abstract][Full Text] [Related]
11. Biotinylated geldanamycin.
Clevenger RC; Raibel JM; Peck AM; Blagg BS
J Org Chem; 2004 Jun; 69(13):4375-80. PubMed ID: 15202892
[TBL] [Abstract][Full Text] [Related]
12. Fluorine- and rhenium-containing geldanamycin derivatives as leads for the development of molecular probes for imaging Hsp90.
Wuest F; Bouvet V; Mai B; LaPointe P
Org Biomol Chem; 2012 Sep; 10(33):6724-31. PubMed ID: 22825378
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of Hsp90 isoforms in geldanamycin-treated 9L cells.
Chang YS; Lo CW; Sun FC; Chang MD; Lai YK
Biochem Biophys Res Commun; 2006 May; 344(1):37-44. PubMed ID: 16630568
[TBL] [Abstract][Full Text] [Related]
14. Heat shock protein-90 inhibitors: a chronicle from geldanamycin to today's agents.
Chiosis G; Caldas Lopes E; Solit D
Curr Opin Investig Drugs; 2006 Jun; 7(6):534-41. PubMed ID: 16784024
[TBL] [Abstract][Full Text] [Related]
15. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
[TBL] [Abstract][Full Text] [Related]
16. High-throughput screening assay for inhibitors of heat-shock protein 90 ATPase activity.
Rowlands MG; Newbatt YM; Prodromou C; Pearl LH; Workman P; Aherne W
Anal Biochem; 2004 Apr; 327(2):176-83. PubMed ID: 15051534
[TBL] [Abstract][Full Text] [Related]
17. Heat-shock protein 90 (Hsp90) as a molecular target for therapy of gastrointestinal cancer.
Moser C; Lang SA; Stoeltzing O
Anticancer Res; 2009 Jun; 29(6):2031-42. PubMed ID: 19528462
[TBL] [Abstract][Full Text] [Related]
18. Quantum chemical calculations and mutational analysis suggest heat shock protein 90 catalyzes trans-cis isomerization of geldanamycin.
Lee YS; Marcu MG; Neckers L
Chem Biol; 2004 Jul; 11(7):991-8. PubMed ID: 15271357
[TBL] [Abstract][Full Text] [Related]
19. A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues.
Gooljarsingh LT; Fernandes C; Yan K; Zhang H; Grooms M; Johanson K; Sinnamon RH; Kirkpatrick RB; Kerrigan J; Lewis T; Arnone M; King AJ; Lai Z; Copeland RA; Tummino PJ
Proc Natl Acad Sci U S A; 2006 May; 103(20):7625-30. PubMed ID: 16684877
[TBL] [Abstract][Full Text] [Related]
20. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation.
Grenert JP; Sullivan WP; Fadden P; Haystead TA; Clark J; Mimnaugh E; Krutzsch H; Ochel HJ; Schulte TW; Sausville E; Neckers LM; Toft DO
J Biol Chem; 1997 Sep; 272(38):23843-50. PubMed ID: 9295332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]